Published on: 7 December 2020 New data presented at ASH 2020 reinforces the benefit/risk profile of fixed-duration Polivy plus bendamustine and MabThera/Rituxan in patients with relapsed or refractory diffuse large B-cell lymphoma more
Published on: 7 December 2020 New follow-up phase III data reinforce the long-term benefit of Roche’s Hemlibra for people with haemophilia A more
Subscribe to Roche News Trang cá độ bóng đá uy tínGet the latest news and updates to your inbox. more
